Innoviva

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Innoviva and other ETFs, options, and stocks.

About INVA

Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. 

CEO
Pavel Raifeld
CEOPavel Raifeld
Employees
127
Employees127
Headquarters
Burlingame, California
HeadquartersBurlingame, California
Founded
1996
Founded1996
Employees
127
Employees127

INVA Key Statistics

Market cap
1.22B
Market cap1.22B
Price-Earnings ratio
58.29
Price-Earnings ratio58.29
Dividend yield
Dividend yield
Average volume
746.50K
Average volume746.50K
High today
$19.66
High today$19.66
Low today
$19.30
Low today$19.30
Open price
$19.54
Open price$19.54
Volume
403.23K
Volume403.23K
52 Week high
$22.00
52 Week high$22.00
52 Week low
$16.67
52 Week low$16.67

INVA News

Simply Wall St 7d
We Think Innoviva Can Manage Its Debt With Ease

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the vol...

We Think Innoviva Can Manage Its Debt With Ease

People also own

Based on the portfolios of people who own INVA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.